Selected article for: "liver disease and low average"

Author: Wingert, A.; Pillay, J.; Gates, M.; Guitard, S.; Rahman, S.; Beck, A.; Vandermeer, B.; Hartling, L.
Title: Risk factors for severe outcomes of COVID-19: a rapid review
  • Cord-id: z1o8ls6q
  • Document date: 2020_9_1
  • ID: z1o8ls6q
    Snippet: Background: Identification of high-risk groups is needed to inform COVID-19 vaccine prioritization strategies in Canada. A rapid review was conducted to determine the magnitude of association between potential risk factors and risk of severe outcomes of COVID-19. Methods: Methods, inclusion criteria, and outcomes were prespecified in a protocol that is publicly available. Ovid MEDLINE(R) ALL, Epistemonikos COVID-19 in LOVE Platform, and McMaster COVID-19 Evidence Alerts, and select websites were
    Document: Background: Identification of high-risk groups is needed to inform COVID-19 vaccine prioritization strategies in Canada. A rapid review was conducted to determine the magnitude of association between potential risk factors and risk of severe outcomes of COVID-19. Methods: Methods, inclusion criteria, and outcomes were prespecified in a protocol that is publicly available. Ovid MEDLINE(R) ALL, Epistemonikos COVID-19 in LOVE Platform, and McMaster COVID-19 Evidence Alerts, and select websites were searched to 15 June 2020. Studies needed to be conducted in Organisation for Economic Co-operation and Development countries and have used multivariate analyses to adjust for potential confounders. After piloting, screening, data extraction, and quality appraisal were all performed by a single reviewer. Authors collaborated to synthesize the findings narratively and appraise the certainty of the evidence for each risk factor-outcome association. Results: Of 3,740 unique records identified, 34 were included in the review. The studies included median 596 (range 44 to 418,794) participants with a mean age between 42 and 84 years. Half of the studies (17/34) were conducted in the United States and 19/34 (56%) were rated as good quality. There was low or moderate certainty evidence for a large ([≥]2-fold) association with increased risk of hospitalization in people having confirmed COVID-19, for the following risk factors: obesity class III, heart failure, diabetes, chronic kidney disease, dementia, age over 45 years (vs. younger), male gender, Black race/ethnicity (vs. non-Hispanic white), homelessness, and low income (vs. above average). Age over 60 and 70 years may be associated with large increases in the rate of mechanical ventilation and severe disease, respectively. For mortality, a large association with increased risk may exist for liver disease, Bangladeshi ethnicity (vs. British white), age over 45 years (vs. <45 years), age over 80 years (vs. 65-69 years), and male gender in those 20-64 years (but not older). Associations with hospitalization and mortality may be very large ([≥]5-fold increased risk) for those aged over 60 years. Conclusion: Among other factors, increasing age (especially >60 years) appears to be the most important risk factor for severe outcomes among those with COVID-19. There is a need for high quality primary research (accounting for multiple confounders) to better understand the level of risk that might be associated with immigration or refugee status, religion or belief system, social capital, substance use disorders, pregnancy, Indigenous identity, living with a disability, and differing levels of risk among children. PROSPERO registration: CRD42020198001

    Search related documents:
    Co phrase search for related documents
    • acceptability feasibility and acute respiratory sars syndrome: 1, 2, 3, 4, 5, 6
    • acceptability feasibility and acute respiratory syndrome: 1, 2, 3, 4, 5, 6
    • acceptability feasibility and liver disease: 1, 2, 3
    • acceptability feasibility and low certainty: 1, 2, 3, 4, 5
    • acceptability feasibility equity and acute respiratory: 1, 2
    • acceptability feasibility equity and acute respiratory sars syndrome: 1, 2
    • acceptability feasibility equity and acute respiratory syndrome: 1, 2
    • acceptability feasibility equity and low certainty: 1, 2, 3, 4, 5
    • acceptability framework and acute respiratory: 1
    • acceptability framework and acute respiratory sars syndrome: 1
    • acceptability framework and acute respiratory syndrome: 1
    • acceptability framework feasibility and acute respiratory: 1
    • acceptability framework feasibility and acute respiratory sars syndrome: 1
    • acceptability framework feasibility and acute respiratory syndrome: 1
    • acceptability framework feasibility equity and acute respiratory: 1
    • acceptability framework feasibility equity and acute respiratory sars syndrome: 1
    • acceptability framework feasibility equity and acute respiratory syndrome: 1
    • acute respiratory and adjustment lack: 1, 2
    • acute respiratory and liver disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25